Skip to content
Study details
Enrolling now

Cannabis for Palliative Care in Cancer

University of Colorado, Boulder
NCT IDNCT06266611ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

185

Study length

about 3.8 years

Ages

25+

Locations

1 site in CO

What this study is about

Researchers are testing a treatment with hemp-derived CBD (Cannabidiol) and THC (Delta-9-tetrahydrocannabinol), or placebo, to see if it helps with pain, sleep, mood, cognitive function, and quality of life in adults with cancer. The trial will last for 1383 days.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take Placebo
  • 2.Take bsCBD Cannabidiol
  • 3.Take fsCBD Cannabidiol

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Oral

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug routes

oral (Oral Solution)

Endpoints

Primary: Fatigue, Health Related Quality of Life, PROMIS Pain Intensity (Right Now), Pain Intensity, Pain Interference, Pain Inventory

Secondary: Polypharmacy for Pain

Body systems

Psychiatry / Mental Health